Pfizer company (NYSE: PFE) has received a consensus rating of “Hold” from the 15 analysts presently doing coverage on the firm. This is according to the report of Marketbeat. Twelve analysts have given ratings of “hold” while two have issued ratings of “buy” on the PFE stock. The average price objective for twelve months among analysts was $41.36 during the past year.
Analyst Reports On The PFE Stock!
The PFE shares have been the topic of several analyst reports. JP Morgan has issued a price target of $40.00 while issuing a rating of “neutral” on the shares of the company in their research report of Monday, 24th May. TheStreet changed their rating on the shares of the company from “c+” to a “-b” in their research report on Monday, 3rd May.
Berenberg Bank reissued a rating of “neutral” while setting a price target of $43.00 on the PFE stock in their research report of Tuesday, 15th June. SVB Leerink elevated their price target from $39.00 – $43.00 while issuing a rating of “market perform” on the shares of the company in their research report of Wednesday, 5th May. Finally, Mizuho reissued a rating of “neutral” while setting a price target of $42.00 on the PFE stock in their research report of Wednesday, 12th May.
The Pfizer shares opened on Thursday at $39.35 in the stock market. The moving average of the business for fifty days is $39.42. The shares have $220.27 bn as its market capitalization, a 20.08 PE ratio, a 1.41 P/E/G ratio, and a 0.74 beta. Pfizer has $33.10 as its one-year low and $43.08 as its one-year high. The shares have a 0.51 ratio between the debt and equity, a 1.48 current ratio, and a 1.16 quick ratio.
